1<!DOCTYPE html>
2
3Anonymous
4/bestp
5/bestp/domrep.nsf
684EE33FF4E3FFB9085256E890066FB17
8
9
10
11
12
13
140
15
16
17/bestp/domrep.nsf/products/selecting-effective-and-productive-investigators-for-clinical-trials?opendocument
18
19opendocument
2034.236.216.93
21
22
23www.best-in-class.com
24/bestp/domrep.nsf
25DB




Products & Services Clinical Operations Clinical Trial Investigators

Selecting Effective and Productive Investigators for Clinical Trials

DB Image

ID: 4623


Features:

Metrics, Graphics


Pages/Slides: 21


Published: Pre-2014


Delivery Format: Online PDF Document


 

License Options:
close

Single User: Authorizes use by the person who places the order or for whom the order was placed.

Sitewide: Authorizes use of the report for a geographic site. All people at site can view the report for a year and copies can be printed.

Corporate: Authorizes use for the entire company for a year and copies can be printed. No limitations for usage inside the company.




Buy Now

 

919-403-0251

  • STUDY OVERVIEW
  • BENCHMARK CLASS
  • BROWSE SELECTED PAGES
  • SPECIAL OFFER
Study Overview

Selecting top-notch clinical investigators is the most crucial step in the clinical trial process. This 21-page document will enable pharmaceutical and CRO executives to fine-tune their selection process by learning about the successful tactics of leading companies.

Key Topics

  • How to plan for the selection process
  • How to set the selection criteria
  • How to optimize the pre-study site assessment.
Sample Best Practices
1. Focus on an investigator’s referral structure to select investigators likely to deliver treatment-naive patients.
- One CRO has made the referral network a significant factor to study and probe during site assessments.
2. Use a competitive recruitment model to select motivated investigators and accelerate study timelines.
- One CRO executes a competitive recruitment process with the first sites that can complete documentation and IRB approval.
3. Develop non-traditional site selection criteria when dealing with inexperienced investigators to determine their appropriateness for participation in a study.
- When determining the criteria for selecting investigators who do not have a track record, one benchmarked pharmaceutical company relies in part upon the eagerness of the investigator and the quality of his or her CV.

Methodology
This research originated from a Best Practices, LLC consulting project. It was conducted on behalf of a pharmaceutical client and was based on interviews and surveys with pharmaceutical benchmark partners, CRO executives as well as several investigators.

Industries Profiled:
Pharmaceutical; Research; Biotech; Medical Device


Companies Profiled:
AAI Development; Amgen; AstraZeneca; Bristol-Myers Squibb; Covance; Lilly; GlaxoSmithKline; ICON; Janssen; PPD; Baxter Healthcare

Browse Selected Pages
Click on an image below to see the full PDF version

Cover Page
Cover Page
Sample Page 1
Sample Page 1
Sample Page 2
Sample Page 2

If you purchase Best Practice Database document(s), you will have 30 days from the date of purchase to apply some or all of the cost of the document(s) toward the cost of a Full Access Individual, Pharma, Group or University Membership. Write us at DatabaseTeam@bestpracticesllc.com or call David Guinn at 919-767-9179 if you have any questions.